Advertisement

Clinical & Experimental Metastasis

, Volume 23, Issue 1, pp 33–39 | Cite as

Tissue array-based expression of transglutaminase-2 in human breast and ovarian cancer

  • Christian F SingerEmail author
  • Gernot Hudelist
  • Ingrid Walter
  • Ernst Rueckliniger
  • Klaus Czerwenka
  • Ernst Kubista
  • Ambros V Huber
Original Paper

Abstract

Transglutaminase-2 is involved in the physiological regulation of cell growth, but has also been associated with a number of cancer-associated features such as cell adhesion, metastasis and extracellular matrix modulation. Despite its importance in tumor cell progression and survival, relatively little is known about its expression in human malignancies. We have therefore investigated the transglutaminase-2 expression pattern in breast and ovarian cancer by using tissue arrays which contained 57 invasive breast cancer biopsies and 62 ovarian cancers, and compared it to transglutaminase-2 protein levels in normal human tissues. By using immunohistochemistry, transglutaminase-2 protein was detected in 48 of 57 breast tumors (84%), with epithelial expression in 26 of 41 (63%) ductal invasive carcinomas and in all 6 (100%) lobular invasive carcinomas. Stromal transglutaminase-2 was present in 14 of 41 (34%) ductal subtypes and in 4 of 6 (67%) lobular subtypes, which is in sharp contrast to the infrequent expression in normal breast stroma (P<0.001, Mann–Whitney test) and somewhat also in normal breast epithelium (P = 0.065, Mann–Whitney test). In most other human tissues, transglutaminase-2 protein was less frequent and usually confined to either the epithelium or in adjacent stroma. In ovarian tumors, the protein was detected in 36 of the 62 cases (58%), and seen in all histological subtypes. Taken together, we have demonstrated increased transglutaminase-2 protein expression in both malignant breast epithelium and surrounding stroma, although its selective spatial expression pattern in normal tissues also indicates a physiological role in stromal–epithelial interactions.

Keywords

Transglutaminase-2 TARP  Human malignancies 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Volokhina EB, Hulshof R, Haanen C, Vermes I (2003 Dec) Tissue transglutaminase mRNA expression in apoptotic cell death. Apoptosis 8(6):673–679CrossRefGoogle Scholar
  2. 2.
    Milakovic T, Tucholski J, McCoy E, Johnson GV (2004 Mar 5) Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. J Biol Chem 279(10):8715–8722CrossRefGoogle Scholar
  3. 3.
    Antonyak MA, Singh US, Lee DA, Boehm JE, Combs C, Zgola MM, Page RL, Cerione RA (2001 Sep 7) Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis. J Biol Chem 276(36):33582–33587CrossRefGoogle Scholar
  4. 4.
    Dieterich W, Esslinger B, Schuppan D (2003 Oct) Pathomechanisms in celiac disease Int Arch Allergy Immunol 132(2):98–108CrossRefGoogle Scholar
  5. 5.
    Akimov SS, Krylov D, Fleischman LF, Belkin AM (2000 Feb 21) Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 148(4):825–838CrossRefGoogle Scholar
  6. 6.
    Stephens P, Grenard P, Aeschlimann P, Langley M, Blain E, Errington R, Kipling D, Thomas D, Aeschlimann D (2004 Jul 1) Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J Cell Sci 117(Pt 15):3389–3403CrossRefGoogle Scholar
  7. 7.
    Jones RA, Nicholas B, Mian S, Davies PJ, Griffin M (1997 Oct) Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin. J Cell Sci 110( Pt 19):2461–2472Google Scholar
  8. 8.
    Mishra S, Murphy LJ (2004 Jun 4) Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. J Biol Chem 279(23):23863–23868CrossRefGoogle Scholar
  9. 9.
    Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RH (2003 Dec 15) Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 63(24):8614–8622Google Scholar
  10. 10.
    Mehta K (1994 Aug 1) High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells. Int J Cancer 58(3):400–406CrossRefGoogle Scholar
  11. 11.
    Fesus L, Piacentini M (2002 Oct) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27(10):534–539CrossRefGoogle Scholar
  12. 12.
    Lesort M, et al (2000) Tissue transglutaminase: a possible role in neurodegenerative diseases. Prog Neurobiol 61:439–463PubMedCrossRefGoogle Scholar
  13. 13.
    Ballestar E, et al (2001) Conformational changes in the nucleosome followed by the selective accessibility of histone glutamines in the transglutaminase reaction: effects of salt concentrations. Biochemistry 40:1922–1929PubMedCrossRefGoogle Scholar
  14. 14.
    Singh US, et al (1995) Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nuclei. Biochemistry 34:15863–15874PubMedCrossRefGoogle Scholar
  15. 15.
    Fesus et al (1987) Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 224:104–108PubMedCrossRefGoogle Scholar
  16. 16.
    Aeschlimann D, Thomazy V (2000) Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect Tissue Res 41(1):1–27PubMedCrossRefGoogle Scholar
  17. 17.
    Akimov SS, Belkin AM (2001 Aug) Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFbeta-dependent matrix deposition. J Cell Sci 114(Pt 16):2989–3000Google Scholar
  18. 18.
    Balklava Z, Verderio E, Collighan R, Gross S, Adams J, Griffin M (2002 May 10) Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion. J Biol Chem 277(19):16567–16575CrossRefGoogle Scholar
  19. 19.
    Sakai K, Busby WH Jr, Clarke JB, Clemmons DR (2001 Mar 23) Tissue transglutaminase facilitates the polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) and leads to loss of IGFBP-1ȁ9s ability to inhibit insulin-like growth factor-I-stimulated protein synthesis. J Biol Chem 276(12):8740–8745CrossRefGoogle Scholar
  20. 20.
    Kim HS, Ingermann AR, Tsubaki J, Twigg SM, Walker GE, Oh Y (2004 Mar 15) Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells. Cancer Res 64(6):2229–2237CrossRefGoogle Scholar
  21. 21.
    Mehta K (1994 Aug 1) High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells. Int J Cancer 58(3):400–406CrossRefGoogle Scholar
  22. 22.
    Han JA, Park SC (1999) Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer cell line. J Cancer Res Clin Oncol 125(2):89–95PubMedCrossRefGoogle Scholar
  23. 23.
    Han JA, Park SC (1999 Jun 30) Hydrogen peroxide mediates doxorubicin-induced transglutaminase 2 expression in PC-14 human lung cancer cell line. Exp Mol Med 31(2):83–88Google Scholar
  24. 24.
    Lee CJ, Do BR, Lee JM, Song KW, Kang JS, Park MH (2003 May-Jun) Differential expression of tissue transglutaminase protein in mouse ovarian follicle. In Vivo 17(3):235–8Google Scholar
  25. 25.
    Nardacci R, Lo Iacono O, Ciccosanti F, Falasca L, Addesso M, Amendola A, Antonucci G, Craxi A, Fimia GM, Iadevaia V, Melino G, Ruco L, Tocci G, Ippolito G, Piacentini M (2003 Apr) Transglutaminase type II plays a protective role in hepatic injury. Am J Pathol 162(4):1293–303Google Scholar
  26. 26.
    Ma Y, Koza-Taylor PH, DiMattia DA, Hames L, Fu H, Dragnev KH, Turi T, Beebe JS, Freemantle SJ, Dmitrovsky E (2003 Jul 31) Microarray analysis uncovers retinoid targets in human bronchial epithelial cells. Oncogene 22(31):4924–32CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2006

Authors and Affiliations

  • Christian F Singer
    • 1
    • 7
    Email author
  • Gernot Hudelist
    • 1
    • 2
  • Ingrid Walter
    • 3
  • Ernst Rueckliniger
    • 4
  • Klaus Czerwenka
    • 5
  • Ernst Kubista
    • 1
  • Ambros V Huber
    • 6
  1. 1.Division of Special Gynaecology Vienna Medical UniversityViennaAustria
  2. 2.Department of OB/GYNVillach Hospital ViennaAustria
  3. 3.Department of Embryology and HistologyVeterinary University of Vienna ViennaAustria
  4. 4.Ruecklinger KEGViennaAustria
  5. 5.Department of GynecopathologyUniversity of ViennaViennaAustria
  6. 6.Departmentt of OB/GYN, Division of Obstetrics and Maternal–Fetal MedicineVienna Medical UniversityViennaAustria
  7. 7.Department of Obstetrics and Gynecology, Division of SenologyVienna Medical UniversityViennaAustria

Personalised recommendations